Rampart Investment Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,992
Closed -$87K 373
2020
Q3
$87K Sell
1,992
-13,514
-87% -$598K 0.06% 272
2020
Q2
$683K Buy
15,506
+13,659
+740% +$578K 0.11% 214
2020
Q1
$72K Sell
1,847
-777
-30% -$39.6K 0.03% 389
2019
Q4
$148K Sell
2,624
-7
-0.3% -$390 0.02% 487
2019
Q3
$140K Sell
2,631
-27,200
-91% -$1.46M 0.02% 478
2019
Q2
$1.74M Buy
29,831
+27,109
+996% +$1.46M 0.21% 150
2019
Q1
$135K Buy
2,722
+355
+15% +$15.6K 0.02% 483
2018
Q4
$88K Sell
2,367
-46,766
-95% -$1.7M 0.02% 436
2018
Q3
$97.1K Sell
49,133
-10,644
-18% -$443K 0.04% 404
2018
Q2
$2.62M Buy
59,777
+8,927
+18% +$419K 0.26% 111
2018
Q1
$2.56M Buy
50,850
+48,015
+1,694% +$2.83M 0.24% 124
2017
Q4
$187K Sell
2,835
-376
-12% -$23.9K 0.07% 293
2017
Q3
$192K Buy
3,211
+239
+8% +$14.2K 0.06% 312
2017
Q2
$193K Buy
2,972
+2,331
+364% +$147K 0.07% 305
2017
Q1
$40K Buy
+641
New +$38.6K 0.01% 315

Other funds holding XRAY

Rampart Investment Management's XRAY Position: Q4 2020 in Review

Rampart Investment Management sold out of Dentsply Sirona (XRAY) in Q4 2020, closing a stake of 1,992 shares — an estimated $87K sold.

Rampart Investment Management first reported a position in XRAY in Q1 2017 and held it in 15 quarters. The position peaked at $2.62M in Q2 2018. 533 funds tracked by Wall St. Rank hold XRAY as of Q4 2020.

  • Rampart Investment Management reported no remaining Dentsply Sirona position as of Q4 2020 after selling out during the quarter.
  • Rampart Investment Management sold 1,992 Dentsply Sirona shares in Q4 2020, an estimated $87K.
  • Rampart Investment Management first reported a position in Dentsply Sirona in Q1 2017 and held it in 15 quarters.
  • Rampart Investment Management's Dentsply Sirona position peaked at $2.62M in Q2 2018.
  • 533 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2020.

Based on Rampart Investment Management's 13F filing for Q4 2020.